Reliability and validity of Arabic version of the brief international cognitive assessment for multiple sclerosis: Egyptian dialect

[1] Hamdy SM(2017)Characteristics and predictors of progression in an Egyptian multiple sclerosis cohort: a multicenter registry study Neuropsychiatr Dis Treat 13 1895-1903

[2] Abdel-Naseer M(2016)Prevalence of multiple sclerosis in Al Quseir city, red sea governorate, Egypt Neuropsychiatr Dis Treat 12 155-158

[3] Shalaby NM(2014)MS in Egypt Mult Scler Relat Disord. 3 768-769

[4] Eelmazny AN(1999)Development of a multiple sclerosis functional composite as a clinical trial outcome measure Brain 122 871-882

[5] Nemr AA(2008)Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis Mult Scler J. 14 1250-1261

[6] Hassan A(2017)The clinico-radiological paradox of cognitive function and MRI burden of white matter lesions in people with multiple sclerosis: a systematic review and meta-analysis. Aktas O, editor PLoS One 12 e0177727-477

[7] El-Tallawy HN(1989)Information processing speed in patients with multiple sclerosis J Clin Exp Neuropsychol. 11 471-169

[8] Farghaly WMA(1995)The brief repeatable battery of neuropsychological tests for multiple sclerosis: a preliminary serial study Mult Scler J 1 165-397

[9] Badry R(2002)Minimal neuropsychological assessment of MS patients: a consensus approach Clin Neuropsychol (Neuropsychology, Dev Cogn Sect D) 16 381-129

[10] Metwally NA(2014)Reliability of a cognitive endpoint for use in a multiple sclerosis pharmaceutical trial J Neurol Sci. 340 123-898

[1] Hamdy SM(2017)Characteristics and predictors of progression in an Egyptian multiple sclerosis cohort: a multicenter registry study Neuropsychiatr Dis Treat 13 1895-1903

[2] Abdel-Naseer M(2016)Prevalence of multiple sclerosis in Al Quseir city, red sea governorate, Egypt Neuropsychiatr Dis Treat 12 155-158

[3] Shalaby NM(2014)MS in Egypt Mult Scler Relat Disord. 3 768-769

[4] Eelmazny AN(1999)Development of a multiple sclerosis functional composite as a clinical trial outcome measure Brain 122 871-882

[5] Nemr AA(2008)Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis Mult Scler J. 14 1250-1261

[6] Hassan A(2017)The clinico-radiological paradox of cognitive function and MRI burden of white matter lesions in people with multiple sclerosis: a systematic review and meta-analysis. Aktas O, editor PLoS One 12 e0177727-477

[7] El-Tallawy HN(1989)Information processing speed in patients with multiple sclerosis J Clin Exp Neuropsychol. 11 471-169

[8] Farghaly WMA(1995)The brief repeatable battery of neuropsychological tests for multiple sclerosis: a preliminary serial study Mult Scler J 1 165-397

[9] Badry R(2002)Minimal neuropsychological assessment of MS patients: a consensus approach Clin Neuropsychol (Neuropsychology, Dev Cogn Sect D) 16 381-129

[10] Metwally NA(2014)Reliability of a cognitive endpoint for use in a multiple sclerosis pharmaceutical trial J Neurol Sci. 340 123-898